XML 27 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 11 — Income Taxes

Loss before provision for income taxes includes the following components (in thousands):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

Domestic

 

$

(274,998

)

 

$

(371,900

)

 

$

(524,440

)

Foreign

 

 

(1,258

)

 

 

6,917

 

 

 

1,160

 

Loss before provision for income taxes

 

$

(276,256

)

 

$

(364,983

)

 

$

(523,280

)

 

Provision for Income Taxes

The provision for income taxes consists of the following (in thousands):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

State

 

 

(43

)

 

 

(608

)

 

 

50

 

Foreign

 

 

(17

)

 

 

1,115

 

 

 

609

 

Total current income tax expense

 

 

(60

)

 

 

507

 

 

 

659

 

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

 

 

 

 

State

 

 

 

 

 

 

 

 

 

Foreign

 

 

(140

)

 

 

2,708

 

 

 

(102

)

Total deferred income tax expense

 

 

(140

)

 

 

2,708

 

 

 

(102

)

Provision (benefit) for income taxes

 

$

(200

)

 

$

3,215

 

 

$

557

 

 

Our income tax provision related to continuing operations differs from the amount computed by applying the statutory income tax rate of 21% to our pretax loss as follows (in thousands):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

Income tax benefit at federal statutory rate

 

$

(58,013

)

 

$

(76,647

)

 

$

(109,889

)

Research credits

 

 

(1,192

)

 

 

(987

)

 

 

(4,727

)

Change in valuation allowance

 

 

35,033

 

 

 

51,108

 

 

 

97,914

 

Expiration of net operating loss carryforwards

 

 

312

 

 

 

12,348

 

 

 

286

 

Stock-based compensation

 

 

8,919

 

 

 

15,778

 

 

 

6,627

 

Non-cash interest expense on liability related to sales of future royalties

 

 

5,320

 

 

 

6,071

 

 

 

9,936

 

Non-cash royalty revenue related to sales of future royalties

 

 

(7,838

)

 

 

(7,112

)

 

 

(7,891

)

Loss on revaluation of liability related to the sale of future royalties

 

 

 

 

 

 

 

 

4,940

 

Impairment of goodwill

 

 

16,065

 

 

 

 

 

 

 

Other

 

 

1,194

 

 

 

2,656

 

 

 

3,361

 

Provision (benefit) for income taxes

 

$

(200

)

 

$

3,215

 

 

$

557

 

 

Deferred Tax Assets and Liabilities

Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. We measure deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future. Significant components of our deferred tax assets for federal and state income taxes are as follows (in thousands):

 

 

December 31,

 

 

2023

 

 

2022

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

574,737

 

 

$

545,508

 

Research and other credits

 

 

144,128

 

 

 

142,198

 

Net capital loss carryforwards

 

 

39,655

 

 

 

38,445

 

Operating lease liabilities

 

 

25,384

 

 

 

28,254

 

Stock-based compensation

 

 

19,447

 

 

 

22,110

 

Capitalized research and development costs

 

 

34,675

 

 

 

24,134

 

Liability related to the sale of future royalties

 

 

6,729

 

 

 

13,424

 

Other

 

 

13,863

 

 

 

13,935

 

Deferred tax assets before valuation allowance

 

 

858,618

 

 

 

828,008

 

Valuation allowance for deferred tax assets

 

 

(854,528

)

 

 

(816,235

)

Total deferred tax assets

 

 

4,090

 

 

 

11,773

 

Deferred tax liabilities:

 

 

 

 

 

 

Operating lease right-of-use assets

 

 

(3,824

)

 

 

(11,335

)

Investment in foreign subsidiary

 

 

(521

)

 

 

(2,451

)

Other

 

 

(265

)

 

 

(392

)

Total deferred tax liabilities

 

 

(4,610

)

 

 

(14,178

)

Net deferred tax assets (liabilities)

 

$

(520

)

 

$

(2,405

)

Realization of our deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Because of our lack of U.S. earnings history and projected future losses, we have fully reserved our net U.S. deferred tax assets with a valuation allowance. The valuation allowance increased by $38.3 million for the year ended December 31, 2023 and increased by $30.5 million for the year ended December 31, 2022.

Our net deferred tax liability position reflects the provision for the withholding taxes associated with the repatriation of accumulated earnings and profits from India.

Net Operating Loss and Tax Credit Carryforwards

As of December 31, 2023, we had a net operating loss carryforward for federal income tax purposes of approximately $2.7 billion, of which $1.3 billion is subject to expiration beginning in 2024 and a total state net operating loss carryforward of approximately $0.7 billion, portions of which will begin to expire in 2027. We have federal tax credits of approximately $126.0 million, which will begin to expire in 2024 and state research credits of approximately $59.9 million which have no expiration date. Utilization of some of the federal and state net operating loss and credit carryforwards are subject to annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions.

Unrecognized tax benefits

We have the following activity relating to unrecognized tax benefits (in thousands):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

Beginning balance

 

$

85,845

 

 

$

80,604

 

 

$

78,665

 

Tax positions related to current year:

 

 

 

 

 

 

 

 

 

Additions

 

 

848

 

 

 

378

 

 

 

2,371

 

Reductions

 

 

 

 

 

 

 

 

 

Tax positions related to prior years:

 

 

 

 

 

 

 

 

 

Additions

 

 

40,079

 

 

 

5,272

 

 

 

58

 

Reductions

 

 

 

 

 

 

 

 

(490

)

Settlements

 

 

 

 

 

 

 

 

 

Lapses in statute of limitations

 

 

(274

)

 

 

(409

)

 

 

 

Ending balance

 

$

126,498

 

 

$

85,845

 

 

$

80,604

 

 

If we are eventually able to recognize our uncertain tax positions, our effective tax rate may be reduced. We currently have a full valuation allowance against our U.S. net deferred tax asset which would impact the timing of the effective tax rate benefit should any of these uncertain tax positions be favorably settled in the future. Adjustments to the substantial majority of our uncertain tax positions would result in an adjustment of our net operating loss or tax credit carryforwards rather than resulting in a cash outlay.

We file income tax returns in the U.S., California, Alabama, certain other states and India. As a result of our net operating loss and research credit carryforwards, substantially all of our domestic tax years remain open and subject to examination. We may be subject to examination in India from time to time, but we do not believe that any liability resulting from such an examination would have a material effect on our financial position or results of operations.

Our policy is to include interest and penalties related to unrecognized tax benefits, if any, within the provision for income taxes in the consolidated statements of operations. During the years ended December 31, 2023, 2022 and 2021, no significant interest or penalties were recognized relating to unrecognized tax benefits. Although it is reasonably possible that certain unrecognized tax benefits could change in the future, we do not anticipate any significant changes over the next twelve months.